{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:42:41Z","timestamp":1788925361888,"version":"build-2803163510"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19J13415"],"award-info":[{"award-number":["JP19J13415"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16H05344"],"award-info":[{"award-number":["JP16H05344"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K20617"],"award-info":[{"award-number":["JP20K20617"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016981","name":"Pharmaceutical Society of Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016981","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"MEXT","doi-asserted-by":"publisher","award":["JPMXS0422500320"],"award-info":[{"award-number":["JPMXS0422500320"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,13]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Primary biliary cholangitis (PBC) is characterized by the presence of serum anti-mitochondrial autoantibodies (AMAs). To date, four antigens among the 2-oxo-acid dehydrogenase complex family, which commonly have lipoyl domains as an epitope, have been identified as AMA-corresponding antigens (AMA-antigens). It has recently been reported that AMAs react more strongly with certain chemically modified mimics than with the native lipoyl domains in AMA-antigens. Moreover, high concentrations of circulating immune complexes (ICs) in PBC patients have been reported. However, the existence of ICs formed by AMAs and their antigens has not been reported to date. We hypothesized that AMAs and their antigens formed ICs in PBC sera, and analyzed sera of PBC and four autoimmune diseases (Sj\u00f6gren's syndrome, systemic lupus erythematosus, systemic scleroderma, and rheumatoid arthritis) using immune complexome analysis, in which ICs are separated from serum and are identified by nano-liquid chromatography-tandem mass spectrometry. To correctly assign MS\/MS spectra to peptide sequences, we used a protein-search algorithm that including lipoylation and certain xenobiotic modifications. We found three AMA-antigens, the E2 subunit of the pyruvate dehydrogenase complex (PDC-E2), the E2 subunit of the 2-oxo-glutarate dehydrogenase complex (OGDC-E2) and dihydrolipoamide dehydrogenase binding protein (E3BP), by detecting peptides containing lipoylation and xenobiotic modifications from PBC sera. Although the lipoylated sites of these peptides were different from the well-known sites, abnormal lipoylation and xenobiotic modification may lead to production of AMAs and the formation ICs. Further investigation of the lipoylated sites, xenobiotic modifications, and IC formation will lead to deepen our understanding of PBC pathogenesis.<\/jats:p>","DOI":"10.1111\/cei.13588","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T13:14:28Z","timestamp":1613740468000},"page":"335-343","source":"Crossref","is-referenced-by-count":7,"title":["Investigation of immune complexes formed by mitochondrial antigens containing a new lipoylated site in sera of primary biliary cholangitis patients"],"prefix":"10.1093","volume":"204","author":[{"given":"N","family":"Aibara","sequence":"first","affiliation":[{"name":"Unit of Medical Pharmacy, Department of Pharmacy Practice, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1449-5505","authenticated-orcid":false,"given":"K","family":"Ohyama","sequence":"additional","affiliation":[{"name":"Unit of Medical Pharmacy, Department of Pharmacy Practice, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Clinical Research Center, National Hospital Organization (NHO) Nagasaki Medical Center, Omura, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tamai","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Kishikawa","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry for Pharmaceuticals, Course of Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Tsukamoto","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapeutics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Unit of Medical Pharmacy, Department of Pharmacy Practice, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry for Pharmaceuticals, Course of Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"key":"2021121023261835500_cei13588-bib-0001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2152\/jmi.64.7","article-title":"Primary biliary cholangitis: its pathological characteristics and immunopathological mechanisms","volume":"64","author":"Tsuneyama","year":"2017","journal-title":"J Med Invest"},{"key":"2021121023261835500_cei13588-bib-0002","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jhep.2009.11.027","article-title":"Primary biliary cirrhosis: a 2010 update","volume":"52","author":"Poupon","year":"2010","journal-title":"J Hepatol"},{"key":"2021121023261835500_cei13588-bib-0003","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cca.2010.12.019","article-title":"Disease-specific autoantibodies in primary biliary cirrhosis","volume":"412","author":"Bogdanos","year":"2011","journal-title":"Clin Chim Acta"},{"key":"2021121023261835500_cei13588-bib-0004","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2147\/TCRM.S113052","article-title":"New developments in the treatment of primary biliary cholangitis \u2013 role of obeticholic acid","volume":"13","author":"Jhaveri","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"2021121023261835500_cei13588-bib-0005","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/1756283X17728669","article-title":"Novel strategies and therapeutic options for the management of primary biliary cholangitis","volume":"10","author":"Khanna","year":"2017","journal-title":"Therap Adv Gastroenterol"},{"key":"2021121023261835500_cei13588-bib-0006","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis","volume":"377","author":"Selmi","year":"2011","journal-title":"Lancet"},{"key":"2021121023261835500_cei13588-bib-0007","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cca.2014.08.024","article-title":"Autoantibody profiling of patients with primary biliary cirrhosis using a multiplexed line-blot assay","volume":"438","author":"Villalta","year":"2015","journal-title":"Clin Chim Acta"},{"key":"2021121023261835500_cei13588-bib-0008","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","article-title":"Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"1997","journal-title":"Hepatology"},{"key":"2021121023261835500_cei13588-bib-0009","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/jcp.53.11.813","article-title":"Autoantigens in primary biliary cirrhosis","volume":"53","author":"Jones","year":"2000","journal-title":"J Clin Pathol"},{"key":"2021121023261835500_cei13588-bib-0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpg.2018.05.008","article-title":"Evolution of our understanding of PBC","volume":"34\u201335","author":"Tanaka","year":"2018","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2021121023261835500_cei13588-bib-0011","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/icb.2010.126","article-title":"The autoimmunity of primary biliary cirrhosis and the clonal selection theory","volume":"89","author":"Selmi","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"2021121023261835500_cei13588-bib-0012","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jaut.2011.06.001","article-title":"Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity","volume":"37","author":"Naiyanetr","year":"2011","journal-title":"J Autoimmun"},{"key":"2021121023261835500_cei13588-bib-0013","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.4049\/jimmunol.174.9.5874","article-title":"Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid","volume":"174","author":"Amano","year":"2005","journal-title":"J Immunol"},{"key":"2021121023261835500_cei13588-bib-0014","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2012.12.007","article-title":"Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA","volume":"41","author":"Leung","year":"2013","journal-title":"J Autoimmun"},{"key":"2021121023261835500_cei13588-bib-0015","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/antib4040314","article-title":"The role of pathogenic autoantibodies in autoimmunity","volume":"4","author":"Rowley","year":"2015","journal-title":"Antibodies"},{"key":"2021121023261835500_cei13588-bib-0016","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1006\/jaut.1998.0220","article-title":"Penetration and co-localization in MDCK cell mitochondria of IgA derived from patients with primary biliary cirrhosis","volume":"11","author":"Malmborg","year":"1998","journal-title":"J Autoimmun"},{"key":"2021121023261835500_cei13588-bib-0017","first-page":"95","article-title":"Identification of biliary antigens in circulating immune complexes in primary biliary cirrhosis","volume":"42","author":"Amoroso","year":"1980","journal-title":"Clin Exp Immunol"},{"key":"2021121023261835500_cei13588-bib-0018","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(77)92666-6","article-title":"Is primary biliary cirrhosis an immune complex disease?","volume":"310","author":"Thomas","year":"1977","journal-title":"Lancet"},{"key":"2021121023261835500_cei13588-bib-0019","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1373\/clinchem.2010.157776","article-title":"Immune complexome analysis of serum and its application in screening for immune complex antigens in rheumatoid arthritis","volume":"57","author":"Ohyama","year":"2011","journal-title":"Clin Chem"},{"key":"2021121023261835500_cei13588-bib-0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.clinbiochem.2014.11.008","article-title":"Proteomic profiling of antigens in circulating immune complexes associated with each of seven autoimmune diseases","volume":"48","author":"Ohyama","year":"2015","journal-title":"Clin Biochem"},{"key":"2021121023261835500_cei13588-bib-0021","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jim.2018.06.021","article-title":"Selective, sensitive and comprehensive detection of immune complex antigens by immune complexome analysis with papain-digestion and elution","volume":"461","author":"Aibara","year":"2018","journal-title":"J Immunol Methods"},{"key":"2021121023261835500_cei13588-bib-0022","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cca.2018.05.026","article-title":"Proteomic approach to profiling immune complex antigens in cerebrospinal fluid samples from patients with central nervous system autoimmune diseases","volume":"484","author":"Aibara","year":"2018","journal-title":"Clin Chim Acta"},{"key":"2021121023261835500_cei13588-bib-0023","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cca.2019.05.031","article-title":"Comprehensive immune complexome analysis detects disease-specific immune complex antigens in seminal plasma and follicular fluids derived from infertile men and women","volume":"495","author":"Murakami","year":"2019","journal-title":"Clin Chim Acta"},{"key":"2021121023261835500_cei13588-bib-0024","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"2021121023261835500_cei13588-bib-0025","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1872-034X.2010.00631.x","article-title":"Analysis of HLA-DRB1 polymorphisms in Japanese patients with primary biliary cirrhosis (PBC): the HLA-DRB1polymorphism determines the relative risk of antinuclear antibodies for disease progression in PBC","volume":"40","author":"Nakamura","year":"2010","journal-title":"Hepatol Res"},{"key":"2021121023261835500_cei13588-bib-0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0000000000013450","article-title":"Serum cytokine profiles and Mac-2 binding protein glycosylation isomer (M2BPGi) level in patients with autoimmune hepatitis","volume":"97","author":"Migita","year":"2018","journal-title":"Medicine"},{"key":"2021121023261835500_cei13588-bib-0027","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1042\/bj2770153","article-title":"Lipoylation of the E2 components of the 2-oxo acid dehydrogenase multienzyme complexes of Escherichia coli","volume":"277","author":"Packman","year":"1991","journal-title":"Biochem J"},{"key":"2021121023261835500_cei13588-bib-0028","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/hep.1840100402","article-title":"Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis","volume":"10","author":"Mutimer","year":"1989","journal-title":"Hepatology"},{"key":"2021121023261835500_cei13588-bib-0029","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hep.1840100202","article-title":"Antimitochondrial autoantibodies in primary biliary cirrhosis recognize cross-reactive epitope(s) on protein X and dihydrolipoamide acetyltransferase of pyruvate dehydrogenase complex","volume":"10","author":"Surh","year":"1989","journal-title":"Hepatology"},{"key":"2021121023261835500_cei13588-bib-0030","volume-title":"Cell Mol Immunol","author":"Abbas","year":"2017","edition":"9th"},{"key":"2021121023261835500_cei13588-bib-0031","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10157-005-0357-8","article-title":"Mechanisms of immune-deposit formation and the mediation of immune renal injury","volume":"9","author":"Nangaku","year":"2005","journal-title":"Clin Exp Nephrol"},{"key":"2021121023261835500_cei13588-bib-0032","first-page":"59","article-title":"Complement, antigen\u2013antibody complexes and immune complex disease","volume":"17","author":"Naama","year":"1985","journal-title":"J Clin Lab Immunol"},{"key":"2021121023261835500_cei13588-bib-0033","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2174\/1389202919666191014092843","article-title":"LipoSVM: prediction of lysine lipoylation in proteins based on the support vector machine","volume":"20","author":"Wu","year":"2019","journal-title":"Curr Genomics"},{"key":"2021121023261835500_cei13588-bib-0034","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1093\/emboj\/18.10.2673","article-title":"Structure and selectivity in post-translational modification: attaching the biotinyl-lysine and lipoyl-lysine swinging arms in multifunctional enzymes","volume":"18","author":"Reche","year":"1999","journal-title":"EMBO J"},{"key":"2021121023261835500_cei13588-bib-0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbpa.2017.11.003","article-title":"Protein lipoylation: an evolutionarily conserved metabolic regulator of health and disease","volume":"42","author":"Rowland","year":"2018","journal-title":"Curr Opin Chem Biol"},{"key":"2021121023261835500_cei13588-bib-0036","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.actatropica.2012.10.010","article-title":"A simple immune complex dissociation ELISA for leishmaniasis: standardization of the assay in experimental models and preliminary results in canine and human samples","volume":"125","author":"de Carvalho","year":"2013","journal-title":"Acta Trop"},{"key":"2021121023261835500_cei13588-bib-0037","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/j.1471-4159.2008.05477.x","article-title":"Antigen\u2013antibody dissociation in Alzheimer disease: a novel approach to diagnosis","volume":"106","author":"Gustaw","year":"2008","journal-title":"J Neurochem"},{"key":"2021121023261835500_cei13588-bib-0038","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2202-8-22","article-title":"Improvement of a low pH antigen\u2013antibody dissociation procedure for ELISA measurement of circulating anti-Abeta antibodies","volume":"8","author":"Li","year":"2007","journal-title":"BMC Neurosci"},{"key":"2021121023261835500_cei13588-bib-0039","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1034\/j.1600-0528.2002.017410.x","article-title":"The peculiar autoimmunity of primary biliary cirrhosis","volume":"174","author":"Mackay","year":"2000","journal-title":"Immunol Rev"},{"key":"2021121023261835500_cei13588-bib-0040","doi-asserted-by":"crossref","first-page":"8159","DOI":"10.1038\/s41598-018-26531-0","article-title":"Serum autotaxin is a useful disease progression marker in patients with primary biliary cholangitis","volume":"8","author":"Joshita","year":"2018","journal-title":"Sci Rep"},{"key":"2021121023261835500_cei13588-bib-0041","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/hepr.13361","article-title":"Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis","volume":"49","author":"Joshita","year":"2019","journal-title":"Hepatol Res"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cei.13588","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cei.13588","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/204\/3\/335\/41634684\/cei13588.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/204\/3\/335\/41634684\/cei13588.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:25:23Z","timestamp":1641054323000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/204\/3\/335\/6407872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,22]]},"published-print":{"date-parts":[[2021,5,13]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13588","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6]]},"published":{"date-parts":[[2021,3,22]]}}}